Ignite Creation Date:
2024-05-06 @ 7:14 PM
Last Modification Date:
2024-10-26 @ 3:03 PM
Study NCT ID:
NCT05947448
Status:
RECRUITING
Last Update Posted:
2024-04-01
First Post:
2023-07-07
Brief Title:
Efficacy and Safety of Mexartan Potassium Tablets AZL-M and Calcium Channel Blockers CCB in the Treatment of Adults With Essential Hypertension in Chinese Population a National Multicenter Prospective Observational Study
Sponsor:
Organization:
Hasten Biopharmaceutical Co Ltd